Retina

AMD affects approximately 28 million people in the US and is a leading cause of vision loss among older adults.

Avacincaptad pegol may help preserve driving-related vision in geographic atrophy, but post hoc data did not reach statistical significance.

Ischemic retinal disorders may signal underlying cardiovascular risk, making diagnostic imaging workup essential.

The device is described as “a wireless brain implant designed to provide artificial vision for people with total blindness by bypassing the eyes and optic nerves and connecting directly to the brain’s visual cortex.

ECG-synchronized Doppler holography provides repeatable measurements of the retinal blood flow.

The study, published in PLoS Genetics, examined how glucose metabolism affects gene expression in light-sensing photoreceptors.

Researchers noted growing evidence supporting an additional role for B vitamins.

What to know about the current state of artificial intelligence and multimodal retinal imaging in systemic disease surveillance in eye care.

At 12 weeks, improvements in visual and anatomical outcomes were observed across all groups.

The analysis included 12,183,254 patients, with 304,823 identified as smokers and 11,878,431 as non-smokers.

The decision lengthens the approved treatment period outlined in the prescribing information and may lessen the need to change therapies for patients who continue to show a lasting response.

Images showed that Parkinson disease is associated with a thicker photoreceptor nuclear layer and a thinner layer of photoreceptor processes.

Sex hormones play important but distinct roles in regulating the ocular surface and adnexal tissues.

Phase 2 ArMaDa data show statistically significant 31% reduction in geographic atrophy lesion growth with OCU410 at 12 months, with a favorable safety profile supporting phase 3 development.

Luminopia, formerly cleared by the FDA for amblyopia in children, has begun its foray into IXT with positive data from a preliminary investigation.

Meta-analysis finds refraction change better than axial length thresholds for tracking childhood myopia, urging growth-curve AL monitoring to flag retinal risk.

The ADVISE trial has demonstrated adalimumab’s superior management of intermediate uveitis, posterior uveitis, or panuveitis requiring immunosuppression.

A recent study highlights the efficacy of the FAi implant in patients with NIU-related macular edema, improving BCVA and reducing choroidal thickness.

According to recent data, patients initiating semaglutide had a substantially greater risk of developing NAION versus those starting SGLT2 inhibitors.

In recent months, developments have ranged from regulatory setbacks to real-world data releases.

The prospective observational study is being conducted across 18 countries.

The goal of the study was to investigate the natural history of macular tissue preservation in GA by evaluating the relationship between the MTII and BCVA over time.

A total of 38 patients were included in the study. All underwent implantation of the PRIMA retinal prosthetic chip with the goal of restoring vision.

Two recent journal articles underscore the organ’s importance in identifying systemic disease processes.